RxDoctor Payments Data

Kenneth Lim, MD

Family Medicine · Orlando, FLNPI 1881659308

Payments from drug & device makers

$924in general payments, 2019–2025

Across 22 payments — averaging $42.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$237
  • Novo Nordisk$230
  • Bayer$154
  • Alkermes, Inc.$125
  • Exact Sciences$52
  • Axonics, Inc.$47
  • plus $79 from 3 others

What the payments were for

  • Food & beverage$924100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$924 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$7,197
Medicare patients
17
Services billed
152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban135$120,199
JardianceEmpagliflozin71$88,570
OzempicSemaglutide69$68,850
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$62,621
MounjaroTirzepatide26$28,715
EntrestoSacubitril/Valsartan13$24,927
Breo ElliptaFluticasone/Vilanterol35$23,090
Tresiba Flextouch U-100Insulin Degludec25$16,692
TrulicityDulaglutide12$14,999
SymbicortBudesonide/Formoterol Fumarate39$12,668
JanuviaSitagliptin Phosphate12$9,803
Lantus SolostarInsulin Glargine,hum.Rec.Anlog70$9,303
Albuterol Sulfate HfaAlbuterol Sulfate170$7,350
LantusInsulin Glargine,hum.Rec.Anlog48$6,760
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,113

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$120,199135 claims
Boehringer IngelheimJardiance, Stiolto Respimat$237$93,68382 claims
Novo NordiskOzempic$230$68,85069 claims
Lilly USA, LLCMounjaro, Trulicity$18$43,71438 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →